Literature DB >> 27515038

Can a central blood volume deficit be detected by systolic pressure variation during spontaneous breathing?

Michael Dahl1, Chris Hayes2, Bodil Steen Rasmussen2, Anders Larsson3, Niels H Secher4.   

Abstract

BACKGROUND: Whether during spontaneous breathing arterial pressure variations (APV) can detect a volume deficit is not established. We hypothesized that amplification of intra-thoracic pressure oscillations by breathing through resistors would enhance APV to allow identification of a reduced cardiac output (CO). This study tested that hypothesis in healthy volunteers exposed to central hypovolemia by head-up tilt.
METHODS: Thirteen healthy volunteers were exposed to central hypovolemia by 45° head-up tilt while breathing through a facemask with 7.5 cmH2O inspiratory and/or expiratory resistors. A brachial arterial catheter was used to measure blood pressure and thus systolic pressure variation (SPV), pulse pressure variation and stroke volume variation . Pulse contour analysis determined stroke volume (SV) and CO and we evaluated whether APV could detect a 10 % decrease in CO.
RESULTS: During head-up tilt SV decreased form 91 (±46) to 55 (±24) mL (mean ± SD) and CO from 5.8 (±2.9) to 4.0 (±1.8) L/min (p < 0.05), while heart rate increased (65 (±11) to 75 (±13) bpm; P < 0.05). Systolic pressure decreased from 127 (±14) to 121 (±13) mmHg during head-up tilt, while SPV tended to increase (from 21 (±15)% to 30 (±13)%). Yet during head-up tilt, a SPV ≥ 37 % predicted a decrease in CO ≥ 10 % with a sensitivity and specificity of 78 % and 100 %, respectively.
CONCLUSION: In spontaneously breathing healthy volunteers combined inspiratory and expiratory resistors enhance SPV during head-up tilted induced central hypovolemia and allow identifying a 10 % reduction in CO. Applying inspiratory and expiratory resistors might detect a fluid deficit in spontaneously breathing patients. TRIAL REGISTRATION: ClinicalTrials.gov number NCT02549482 Registered September 10(th) 2015.

Entities:  

Keywords:  Fluid responsiveness; Head-up tilt; Pulse pressure variation; Spontaneous breathing; Stroke volume variation; Systolic pressure variation

Mesh:

Year:  2016        PMID: 27515038      PMCID: PMC4982018          DOI: 10.1186/s12871-016-0224-z

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN: 1471-2253            Impact factor:   2.217


Key messages

In spontaneous breathing healthy volunteers combined inspiratory and expiratory resistors enhance systolic pressure variation and allow for identifying a central volume deficit with a sensitivity and specificity of 78 % and 100 %, respectively. Combined inspiratory and expiratory resistors might help detecting a fluid deficit in spontaneously breathing patients.

Background

Fluid therapy is an integrated part of emergency and critical care medicine as in anesthesia. However, there are few measurements that asses hypovolemia and consequently to what extent a patient is in need of fluid, i.e. responds with improved cardiovascular function after volume administration (being “fluid responsive”) [1]. Unfortunately, clinical judgment or, e.g. recording of central venous pressure [2-7] does not provide adequate information whether a patient is in need of intravascular volume expansion. In mechanically ventilated patients without cardiac arrhythmias exposed to a tidal volume larger than 8 mL/kg lean body weight, arterial pressure variation (APV) predicts volume responsiveness defined as an increase in stroke volume (SV) or cardiac output (CO) when the patient is exposed to an intravascular volume load [8-14]. In spontaneously breathing patients however, APV is insufficient to guide volume therapy [15-17] and thus volume therapy is guided by recording of SV and/or CO response or change in end-tidal CO2 tension , e.g. when the patient is exposed to passive raising the legs [16, 18–20] or Trendelenburg’s position [21]. Noteworthy, Zaniboni et al. [22] found a correlation for APV between mechanically ventilated patients and patients ventilated by spontaneous flow triggered synchronized intermittent mechanical ventilation. Yet, APV can detect fluid responsiveness as demonstrated in swine breathing through an inspiratory and expiratory resistor that augment pulse pressure variations (PPV) [23] and in healthy volunteers with paced breathing and/or respiratory resistors [24]. Similarly, we considered whether the intra-thoracic pressure oscillations when amplified by inspiratory (increasing the negative intra-thoracic pressure) and expiratory resistors (increasing the expiratory intra-thoracic pressure) would allow detection of an intravascular volume deficit in humans. In this study, we tested that hypothesis in healthy humans exposed to a reduction in the central blood volume by head-up tilt. Separate evaluation was made by providing the subjects to an inspiratory resistance, to an expiratory resistance, or to both with no application of resistors serving as control. We aimed to identify which expression of APV is most sensitive to a significant reduction of the central blood volume resulting in a 10 % reduction in CO.

Methods

Thirteen healthy volunteers (four women) 25 years (range 18–36) of age (Table 1) were recruited through www.forsogsperson.dk. Exclusion criteria were pregnancy, breast-feeding or use of any medication. The protocol was approved by the ethics committee for human research for The Capital region of Denmark (H-4-2010-110) in accordance with the Helsinki II declaration and oral and written informed consent was obtained.
Table 1

Characteristics of the subjects (n = 13)

Gender (F/M)4/9
Age (years)25 ± 5
Height (cm)178 ± 10
Weight (kg)73 ± 13
BMI (kg/m2)23.0 ± 3.2
BSA (m2)1.9 ± 0.2

Values are mean ± standard deviation

BMI body mass index, BSA body surface area

Characteristics of the subjects (n = 13) Values are mean ± standard deviation BMI body mass index, BSA body surface area The volunteers were placed supine on a tilt table with heart rate monitored by a three-lead ECG and arterial oxygen saturation by pulse oximetry (SpO2) (Philips SpO2 Sensor M1191BL ViCare Medical, Denmark) on the right third finger of the dominant hand. A peripheral venous access was established and a 20 G arterial catheter was placed in the brachial artery of the non-dominant arm and both were maintained by infusion of isotonic saline (3 mL/h). The arterial catheter was connected to a transducer kept at heart level for registration of arterial pressure and stroke volume variation (SVV) (Vigileo-Flotrac™, version 1.07, Edwards Lifesciences, Nyon, Switzerland) as well as blood gas variables (ABL, Radiometer, Copenhagen). CO and the arterial pressure curve were stored for subsequent determination of arterial pulse pressure (PPV) and systolic pressure variation (SPV). Finally, a catheter was placed via a brachial vein and advanced to the subclavian vein to register central venous oxygen saturation (ScvO2) (ABL, Radiometer, Copenhagen). The subjects were breathing spontaneously with respiratory rate determined by capnography (Philips CO2 Filterline, ViCare Medical, Denmark) and provided with a facemask (Intersurgical Ltd., Wokingham, Berkshire, UK) (Fig. 1) randomly fitted with an inspiratory resistor, an expiratory resistor, a combination of the two resistors, or with no resistors. Each resistor provided a 7.5 cmH2O threshold resistance (CPAP; Philips Respironics, Herrshing, Germany) and were applied for two minutes [18] with variables obtained in the second minute.
Fig. 1

Left: four respiratory resistors: no resistance, expiratory resistance, inspiratory resistance, and both inspiratory and expiratory resistances. Right: facemask applied with combined inspiratory and expiratory resistors (Model photo)

Left: four respiratory resistors: no resistance, expiratory resistance, inspiratory resistance, and both inspiratory and expiratory resistances. Right: facemask applied with combined inspiratory and expiratory resistors (Model photo) Initially, variables were recorded with each resistor configuration while the subjects were supine (normovolemia). Secondly, the table was tilted 45° head-up to reduce the central blood volume hence simulating hypovolemia [25] (Fig. 2). Finally, 20° head-down tilt was used to expand the central blood volume and hence simulating mild hypervolemia [25, 26] . After each change of the tilt table position we allowed a 10 min equilibration time before variables were obtained.
Fig. 2

Three postures representing normovolemia (supine), central hypovolemia (head-up tilt), and central hypervolemia (head-down tilt)

Three postures representing normovolemia (supine), central hypovolemia (head-up tilt), and central hypervolemia (head-down tilt) PPV was ((PPmax – PPmin)/((PPmax + PPmin)/2)) × 100, where PPmax and PPmin are the maximal and minimal difference between systolic and diastolic pressure during the respiratory cycle, respectively [12] and SPV was calculated by an analogous formula. PPV and SPV were calculated from the stored recordings, while other variables were noted on-line.

Statistics

For a 1-beta (power) of 0.8 and an alpha (P) of 0.05 and assuming an increase in arterial pressure variations by 10 % with a SD of 5 % by the intervention, a minimum of 8 subjects were needed. Statistics was performed with Stata 13.0 (StataCorp LP, Texas, USA) and QQ-plots identified that the data were normally distributed. Hemodynamic and respiratory responses were analyzed by using a two-way ANOVA with interaction between position and resistor. Estimation of fluid responsiveness was carried out using an ANOVA model with resistor as factor, only for head-up tilt, and Receiver Operating Characteristic (ROC) (Hanley and McNeil’s method). A P value < 0.05 was considered statistically significant.

Results

Hemodynamic responses and blood gas variables

From the supine position to head-up tilt CO decreased from 5.8 (±2.9) to 4.0 (±1.8) L/min (mean ± SD), SV from 91 (±46) to 55 (±24) ml, systolic pressure from 127 (±14) to 121 (±13) mmHg and ScvO2 from 0.79 (±0.07)% to 0.68 (±0.13)%, while diastolic pressure (64 (±7) to 69 (±6) mmHg) and heart rate (65 (±11) to 75 (±13) bpm) increased (P < 0.05). Similarly, from the supine position to head-down tilt there was a decrease in CO, SV and systolic pressure but no changes in heart rate, diastolic pressure or ScvO2 (Table 2). There were no changes in respiratory rate or SpO2 between the three body positions and only small changes in arterial blood gas variables and no significant interactions between position and respiratory resistor application.
Table 2

Hemodynamic and respiratory variables at three postures whatever respiratory resistor(s) applied

Supine positionHead-up tiltHead-down tilt
Cardiac output (L/min)5.8 ± 2.94.0 ± 1.8*5.1 ± 2.2*
Stroke Volume (mL)91 ± 4655 ± 24*81 ± 36*
Systolic blood pressure (mmHg)127 ± 14121 ± 13*120 ± 11*
Diastolic blood pressure (mmHg)64 ± 769 ± 6*65 ± 6
Heart rate (min−1)65 ± 1175 ± 13*65 ± 11
Respiratory rate (min−1)10 ± 410 ± 410 ± 3
Central venous oxygen saturation0.79 ± 0.070.68 ± 0.130.79 ± 0.09
Ph7.43 ± 0.037.45 ± 0.04*7.44 ± 0.04
Oxygen partial pressure (kPa)14.1 ± 1.614.3 ± 1.014.7 ± 1.6*
Carbondioxid partial pressure (kPa)5.0 ± 0.64.6 ± 0.7*4.8 ± 0.7*

Values are mean ± standard deviation. *P < 0.05 compared to the supine position

There was no interaction between position and application of resistors

Hemodynamic and respiratory variables at three postures whatever respiratory resistor(s) applied Values are mean ± standard deviation. *P < 0.05 compared to the supine position There was no interaction between position and application of resistors

Detecting central hypovolemia

Ten volunteers showed a ≥ 10 % decrease in CO between the supine and head-up tilt positions. Regardless of tilt table position the combined inspiratory and expiratory resistors increased SVV, SPV and PPV, while the inspiratory resistor increased SPV and PPV and the expiratory resistor only SPV (Table 3). Sensitivity, specificity, positive predictive value, negative predictive value, area under the curve (AUC), and optimal cut-off for these variables, as well as ScvO2 are shown in Table 4. The best prediction of a central volume deficit (a 10 % reduction in CO) was obtained with SPV when the combined resistors were applied. For that configuration SPV tended to increase (from 21 (±15)% to 30 (±13)%) and revealed a sensitivity of 78 % and a specificity of 100 % with a positive predictive value of 100 %, a negative predictive value of 60 %, and an AUC of 0.96 (0.86;1.00) (confidence interval) (Fig. 3) when SPV was larger than 37 %. Figure 4, Panels a-f show ROC-curves for PPV, SVV, ScvO2, systolic blood pressure, heart rate and SV for comparison.
Table 3

Arterial pressure variations with different airway resistors during head-up tilt

No resistor (%)Inspiratory resistor (%)Expiratory resistor (%)Inspiratory/expiratory resistor (%)
Systolic pressure variation17 ± 1126 ± 14*26 ± 18*28 ± 14*
Stroke volume variation15 ± 819 ± 823 ± 7*29 ± 12*
Pulse pressure variation7 ± 49 ± 68 ± 610 ± 6*

Values are mean ± standard deviation. *P < 0.05 compared to no resistor

Table 4

Sensitivity, specificity, positive predictive value and negative predictive value using 10 % difference in cardiac output between supine position to head-up tilt to define central hypovolemia

AUCOptimal cut-off (%)Sensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)
Stroke volume variation
No resistor0.73 (0.46;1.00)136010010043
Expiratory resistor0.82 (0.58;1.00)287010010050
Inspiratory resistor0.75 (0.46;1.00)185010010038
Ins-/expiratory resistor0.58 (0.28;0.88)314010010033
Systolic pressure variation
No resistor0.43 (0.10;0.77)192010010027
Expiratory resistor0.70 (0.37;1.00)3370678840
Inspiratory resistor0.67 (0.25;1.00)3680678950
Ins-/expiratory resistor0.96 (0.86;1.00)377810010060
Pulse pressure variation
No resistor0.83 (0.61;1.00)78010010060
Expiratory resistor0.73 (0.40;1.00)470678840
Inspiratory resistor0.73 (0.42;1.00)75010010038
Ins-expiratory resistor0.59 (0.25;0.93)1267678640
Central venous oxygen saturation
No resistor0.67 (0.29;1.00)715010010040
Expiratory resistor0.46 (0.02;0.90)7050507525
Inspiratory resistor0.42 (0.00;0.88)7750507525
Ins-expiratory resistor0.50 (0.08;0.92)773310010033

AUC area under the curve with confidence interval

Fig. 3

Receiver operating characteristic (ROC) curves during head-up tilt for systolic pressure variation (SPV) with the four different respiratory resistors. Area under the ROC curve 0.43 (0.10; 0.77 ) (confidence interval) for no resistor, 0.67 (0.25 ;1.00) for the inspiratory resistor, 0.70 (0.37; 1.00) for the expiratory resistor, and 0.96 (0.86; 1.00) for the combined inspiratory and expiratory resistor

Fig. 4

Receiver operating characteristic (ROC) curves during head-up tilt with the four different respiratory resistors. a: Pulse pressure variation (PPV) with area under the ROC curve 0.83 (0.61;1.00) (confidence interval) for no resistor, 0.73 (0.42;1.00) for the inspiratory resistor, 0.73 (0.40;1.00) for the expiratory resistor, and 0.59 (0.25;0.93) for the combined inspiratory and expiratory resistor. b: Stroke volume variation (SVV) with area under the ROC curve 0.73 (0.46;1.00) for no resistor, 0.75 (0.46;1.00) for the inspiratory resistor, 0.82 (0.58;1.00) for the expiratory resistor, and 0.58 (0.28;0.88) for the combined inspiratory and expiratory resistor. c: Central venous oxygen saturation (ScvO2) with area under the ROC curve 0.67 (0.29;1.00) for no resistor, 0.42 (0.00;0.88) for the inspiratory resistor, 0.46 (0.02;0.90) for the expiratory resistor, and 0.50 (0.08;0.92) for the combined inspiratory and expiratory resistor. d: Systolic blood pressure with area under the ROC curve 0.70 (0.37;1.00) for no resistor, 0.75 (0.46;1.00) for the inspiratory resistor, 0.68 (0.31;1.00) for the expiratory resistor, and 0.67 (0.34;0.99) for the combined inspiratory and expiratory resistor. e: Heart rate (HR) with area under the ROC curve 0.52 (0.08;0.95) for no resistor, 0.53 (0.11;0.96) for the inspiratory resistor, 0.68 (0.29;1.00) for the expiratory resistor, and 0.63 (0.22;1.00) for the combined inspiratory and expiratory resistor. f: Stroke volume (SV) with area under the ROC curve 0.63 (0.22;1.00) for no resistor, 0.70 (0.36;1.00) for the inspiratory resistor, 0.67 (0.25;1.00) for the expiratory resistor, and 0.60 (0.19;1.00) for the combined inspiratory and expiratory resistor

Arterial pressure variations with different airway resistors during head-up tilt Values are mean ± standard deviation. *P < 0.05 compared to no resistor Sensitivity, specificity, positive predictive value and negative predictive value using 10 % difference in cardiac output between supine position to head-up tilt to define central hypovolemia AUC area under the curve with confidence interval Receiver operating characteristic (ROC) curves during head-up tilt for systolic pressure variation (SPV) with the four different respiratory resistors. Area under the ROC curve 0.43 (0.10; 0.77 ) (confidence interval) for no resistor, 0.67 (0.25 ;1.00) for the inspiratory resistor, 0.70 (0.37; 1.00) for the expiratory resistor, and 0.96 (0.86; 1.00) for the combined inspiratory and expiratory resistor Receiver operating characteristic (ROC) curves during head-up tilt with the four different respiratory resistors. a: Pulse pressure variation (PPV) with area under the ROC curve 0.83 (0.61;1.00) (confidence interval) for no resistor, 0.73 (0.42;1.00) for the inspiratory resistor, 0.73 (0.40;1.00) for the expiratory resistor, and 0.59 (0.25;0.93) for the combined inspiratory and expiratory resistor. b: Stroke volume variation (SVV) with area under the ROC curve 0.73 (0.46;1.00) for no resistor, 0.75 (0.46;1.00) for the inspiratory resistor, 0.82 (0.58;1.00) for the expiratory resistor, and 0.58 (0.28;0.88) for the combined inspiratory and expiratory resistor. c: Central venous oxygen saturation (ScvO2) with area under the ROC curve 0.67 (0.29;1.00) for no resistor, 0.42 (0.00;0.88) for the inspiratory resistor, 0.46 (0.02;0.90) for the expiratory resistor, and 0.50 (0.08;0.92) for the combined inspiratory and expiratory resistor. d: Systolic blood pressure with area under the ROC curve 0.70 (0.37;1.00) for no resistor, 0.75 (0.46;1.00) for the inspiratory resistor, 0.68 (0.31;1.00) for the expiratory resistor, and 0.67 (0.34;0.99) for the combined inspiratory and expiratory resistor. e: Heart rate (HR) with area under the ROC curve 0.52 (0.08;0.95) for no resistor, 0.53 (0.11;0.96) for the inspiratory resistor, 0.68 (0.29;1.00) for the expiratory resistor, and 0.63 (0.22;1.00) for the combined inspiratory and expiratory resistor. f: Stroke volume (SV) with area under the ROC curve 0.63 (0.22;1.00) for no resistor, 0.70 (0.36;1.00) for the inspiratory resistor, 0.67 (0.25;1.00) for the expiratory resistor, and 0.60 (0.19;1.00) for the combined inspiratory and expiratory resistor

Discussion

In spontaneously breathing healthy volunteers application of a 7.5 cmH2O threshold resistance on both the inspiratory and expiratory side of a facemask during head-up tilt induced central hypovolemia enhanced the variation in arterial pressure during the respiratory cycle sufficiently to detect a 10 % reduction in CO. The highest sensitivity (78 %) and specificity (100 %) was observed for SPV with a threshold of 37 %. As a proof of principle, the results are in line with results by Bronzwaer et al. [24]. However, in contrast to the present findings that group found PPV to be superior to SPV. This difference may be due to a lower breathing rate in the Bronzwaer-study and hence larger tidal volume as well as blood pressure measurement by the non-invasive volume clamp method. Furthermore, we did not find any of the more commonly used variables, e.g. ScvO2, SV, heart rate or systolic blood pressure to be superior to SPV when the combined inspiratory and expiratory resistor was applied (Fig. 4, Panel a-f). Head-up tilt [25, 27] as, e.g. lower body negative pressure, eventually combined with heat stress [28] reduces the central blood volume and has the advantage compared to a blood loss that the intervention can be terminated immediately if the subject becomes ill. That central hypovolemia was provoked by head-up tilt was indicated by a decrease in ScvO2 and an increase in heart rate [29]. We found CO and SV also to decrease during head-down tilt, however the reduction was so small that it did not affect ScvO2 significantly and neither Harms et al. [29] nor Bundgaard-Nielsen et al. [30] found a decrease in CO during head-down tilt and only a decrease in SV when the subjects were tilted 90° head-down. Similarly, moderate head-down tilt did not affect heart rate significantly [29, 30]. Variables were obtained after a ten-minute equilibration period in each body position with randomized application of the resistors. A shorter equilibration period, e.g. one minute, is probably enough to register pulse changes during tilt tests [27], but we decided to use a longer period to be sure that the central blood volume was displaced. Our study has several limitations: First, we studied healthy volunteers who may not be representative for a hospitalized population. For example, in an ICU population only 50 % of patients increase CO ≥ 10 % when challenged with a fluid bolus [31]. Furthermore, the subjects were not fasting or told to abstain from heavy physical exercise and caffeinated beverages prior to the experiment. Secondly, our test was “the reverse” of the clinical practice; i.e. we provoked central hypovolemia by tilting the subjects head-up and evaluated the change in CO and arterial pressure variations, and did not study whether these changes would be corrected by fluid administration. The CO decreased by more than 10 % in 10 of 13 subjects when exposed to 45° head-up tilt and a larger tilt angle would likely result in a more significant reduction of CO. However, we used a relatively long equilibration period. Thirdly, we used an uncalibrated pulse contour technic to detect SV and CO [32]. Fourthly, the results depend not only on the resistance of the resistors, but also on the respiratory effort by the subjects. The threshold resistance was set at 7.5 cmH2O and chosen because that level is in accordance with an animal study using SPV to indicate hypovolemia [23]. An airway threshold resistor between 5 and 10 cmH2O is used for positive end-expiratory pressure or continuous positive airway pressure and is accepted by most patients. Finally, we did not control the breathing rate. A fixed slow paced breathing might have enhanced the results as demonstrated by Zöllei et al. [33] and Bronzwaer et al. [24].

Conclusion

Applying inspiratory and expiratory resistors to spontaneously breathing healthy volunteers allows for identifying significant central hypovolemia by recording of systolic pressure variations. The clinical implication of the results is that systolic pressure variations might be used to detect a volume deficit in spontaneously breathing patients.

Abbreviations

APV, arterial pressure variation; CO, cardiac output; CVP, central venous pressure; PPmax, maximal pulse pressure; PPmin, minimal pulse pressure; PPV, pulse pressure variation; ScvO2, central venous oxygen saturation; SPV, systolic pressure variation; SV, stroke volume; SVV, stroke volume variation
  32 in total

Review 1.  Clinical usefulness of respiratory variations in arterial pressure.

Authors:  Sheldon Magder
Journal:  Am J Respir Crit Care Med       Date:  2004-01-15       Impact factor: 21.405

Review 2.  Interactions between respiration and systemic hemodynamics. Part I: basic concepts.

Authors:  François Feihl; Alain F Broccard
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

Review 3.  Prediction of volume responsiveness in critically ill patients with spontaneous breathing activity.

Authors:  Jean-Louis Teboul; Xavier Monnet
Journal:  Curr Opin Crit Care       Date:  2008-06       Impact factor: 3.687

4.  Postural changes in the peripheral blood-flow of normal subjects with observations on vasovagal fainting reactions as a result of tilting, the lordotic posture, pregnancy and spinal anaesthesia.

Authors:  W BRIGDEN; S HOWARTH; E P SHARPEY-SCHAFER
Journal:  Clin Sci       Date:  1950-05-30       Impact factor: 6.124

5.  The use of pulse pressure variation and stroke volume variation in spontaneously breathing patients to assess dynamic arterial elastance and to predict arterial pressure response to fluid administration.

Authors:  Maurizio Cecconi; M Ignacio Monge García; Manuel Gracia Romero; Johannes Mellinghoff; Francesca Caliandro; Robert Michael Grounds; Andrew Rhodes
Journal:  Anesth Analg       Date:  2015-01       Impact factor: 5.108

6.  Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP.

Authors:  F Michard; D Chemla; C Richard; M Wysocki; M R Pinsky; Y Lecarpentier; J L Teboul
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

7.  Blood volume distribution during head-up tilt induced central hypovolaemia in man.

Authors:  S Matzen; G Perko; S Groth; D B Friedman; N H Secher
Journal:  Clin Physiol       Date:  1991-09

8.  Passive leg raising predicts fluid responsiveness in the critically ill.

Authors:  Xavier Monnet; Mario Rienzo; David Osman; Nadia Anguel; Christian Richard; Michael R Pinsky; Jean-Louis Teboul
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

9.  Use of the tilt test in measuring acute blood loss.

Authors:  R Knopp; R Claypool; D Leonardi
Journal:  Ann Emerg Med       Date:  1980-02       Impact factor: 5.721

10.  Using an expiratory resistor, arterial pulse pressure variations predict fluid responsiveness during spontaneous breathing: an experimental porcine study.

Authors:  Michael K Dahl; Simon T Vistisen; Jacob Koefoed-Nielsen; Anders Larsson
Journal:  Crit Care       Date:  2009-03-20       Impact factor: 9.097

View more
  1 in total

1.  Respiratory variations in pulse pressure and photoplethysmographic waveform amplitude during positive expiratory pressure and continuous positive airway pressure in a model of progressive hypovolemia.

Authors:  Ingrid Elise Hoff; Jonny Hisdal; Svein Aslak Landsverk; Jo Røislien; Knut Arvid Kirkebøen; Lars Øivind Høiseth
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.